Shuwei Li

Dr. Shuwei Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Toxicology
Verified
Journal Article
Closed access
SXShenya Xu
Shenya Xu
MLMei Li
Mei Li
YZYudan Zheng
Yudan Zheng
MXMenghuan Xu
Menghuan Xu
JZJieyu Zhou
Jieyu Zhou
MWMeilin Wang
Meilin Wang

28 April 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SLShuwei Li
Shuwei Li
MDMulong Du
Mulong Du
KXKaili Xu
Kaili Xu
SBShuai Ben
Shuai Ben
TZTianru Zhu
Tianru Zhu
MWMeilin Wang
Meilin Wang
Genetic variants in regions encoding 3′ untranslated regions (UTR) of mRNA potentially alter miRNA binding affinity and N6-methyladenosine (m6A) levels to affect gene expression. A better understanding of the association of these variants with colorectal cancer susceptibility could facilitate development of cancer prevention and treatment approaches. Here, we analyzed miRNA expression profiles and integrated genetic analyses from 8,533 individuals to evaluate the effects of altered miRNA-binding sites on colorectal cancer risk. The single-nucleotide polymorphism rs11245997 in the BET1L 3′UTR was significantly associated with colorectal cancer risk. The rs11245997 A allele facilitated BET1L expression by disrupting miR-140–3p binding. It also reduced BET1L m6A modification, which upregulated BET1L expression levels through a mechanism mediated by the m6A methyltransferases (METTL14 and WTAP) and the m6A demethylase ALKBH5. Moreover, higher expression of BET1L was associated with advanced tumor stages and poor patient prognosis. Increased BET1L expression promoted growth of colorectal cancer cells in vitro and in vivo, which could be partially rescued with miR-140–3p overexpression. RNA sequencing and pathway analyses indicated that BET1L is associated with the steroid biosynthesis pathway through regulation of HSD17B7, CYP27B1, and COMT. These findings provide insights into the involvement of genetic variants of BET1L in the development and progression of colorectal cancer. Significance: The integration of miRNA expression profiles and genetic variants identified rs11245997 as a colorectal cancer risk-related variant that reduces miR-140–3p binding and m6A modification, leading to BET1L upregulation to promote colorectal tumorigenesis.

21 July 2022 in Cancer Medicine
Verified
Journal Article
Open access
SCSilu Chen
Silu Chen
XCXiangming Cao
Xiangming Cao
SBShuai Ben
Shuai Ben
LZLingjun Zhu
Lingjun Zhu
DGDongying Gu
Dongying Gu
QYQiang Yu
Qiang Yu
Background Colorectal cancer is one of the most common malignant digestive tract tumors with a poor prognosis. RNA 5-methylcytosine (m(5)C) is an important posttranscriptional widespread modification involved in many biological processes. However, the association between genetic variations of m(5)C modification genes and the prognostic value of colorectal cancer remains unclear. Methods We investigated the association between candidate single nucleotide polymorphisms (SNPs) in 13 m(5)C modification genes and colorectal cancer overall survival (OS) after chemotherapy by the Cox regression model. The combined effect of selected SNPs on OS, progression-free survival (PFS), and disease control rate (DCR) was assessed by the number of risk alleles (NRA). The GTEx and TCGA database were used to perform expression qualitative trait locus (eQTL) analysis. Results We identified that two SNPs in YBX1 were associated with OS after chemotherapy (HR = 1.43, p = 0.001 for rs10890208; HR = 1.36, p = 0.025 for rs3862218). A striking dose-response effect between NRA and OS after chemotherapy was found (p(trend) = 0.002). The DCR of patients receiving oxaliplatin chemotherapy in the 3-4 NRA group was markedly reduced in comparison to that in the 0-2 NRA group (OR = 1.49, p = 0.036). Moreover, YBX1 mRNA expression was significantly overexpressed in tumor tissues (p < 0.05) in the TCGA database, and eQTL analysis demonstrated that the two SNPs were associated with YBX1 (p = 0.003 for rs10890208 and p = 0.024 for rs3862218). Conclusion Our study indicates that genetic variants in m(5)C modification genes may mediate changes in YBX1 mRNA levels and affect the chemotherapeutic efficacy of colorectal cancer patients.

14 March 2024 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
HSHengyang Shen
Hengyang Shen
YCYang Chen
Yang Chen
MXMenghuan Xu
Menghuan Xu
JZJieyu Zhou
Jieyu Zhou
CHChangzhi Huang
Changzhi Huang
ZFZan Fu
Zan Fu

5 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
TYTing Yu
Ting Yu
SBShuai Ben
Shuai Ben
LMLing Ma
Ling Ma
LJLu Jiang
Lu Jiang
SCSilu Chen
Silu Chen
LZLingjun Zhu
Lingjun Zhu
Autophagy-related genes have a vital effect on colorectal cancer (CRC) by affecting genomic stability and regulating immune responses. However, the associations between genetic variants in autophagy-related genes and CRC outcomes for chemotherapy therapy remain unclear. The Cox regression model was used to evaluate the associations between single-nucleotide polymorphisms (SNPs) in autophagy-related genes and overall survival (OS) and progression-free survival (PFS) of CRC patients. The results were corrected by the false discovery rate (FDR) correction. We used the logistic regression model to investigate the associations of SNPs with the disease control rate (DCR) of patients. Gene expression analysis was explored based on an in-house dataset and other databases. The associations between gene expression and infiltrating immune cells were evaluated using the Tumor Immune Estimation Resource (TIMER) database. We observed that ATG2B rs17094017 A > T was significantly associated with increased OS (HR = 0.65, 95% CI = 0.50-0.86, P = 2.54×10-3), PFS (HR = 0.76, 95% CI = 0.62-0.93, P = 7.34×10-3), and DCR (OR = 0.60, 95% CI = 0.37-0.96, P = 3.31×10-2) of CRC patients after chemotherapy. The expression of ATG2B was down-expressed in CRC tissues than in adjacent normal tissues. Moreover, ATG2B expression influenced the infiltration of CD8+ T cells, CD4+ T cells, B cells, and T cell receptor signaling pathways, which may inhibit the occurrence of CRC by affecting the immune system. This study suggests that genetic variants in the autophagy-related gene ATG2B play a critical role in predicting the prognosis of CRC prognosis undergoing chemotherapy.

10 March 2025 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
HSHengyang Shen
Hengyang Shen
ZWZhenling Wang
Zhenling Wang
YCYang Chen
Yang Chen
CHChangzhi Huang
Changzhi Huang
LXLei Xu
Lei Xu
ZFZan Fu
Zan Fu